Interleukin-1 blockade: a paradigm shift in the treatment of patients with recurrent pericarditis?

Comment on “Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis”, which was presented at the American Heart Association 2020 Scientific Sessions and published in the New England Journal of Medicine (https://doi.org/10.1056/NEJMoa2027892)
Source: European Heart Journal - Category: Cardiology Source Type: research